Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Service & Software > Renal Denervation (RDN) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Renal Denervation (RDN) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Renal Denervation (RDN) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-01-02

Pages: 104 Pages

Report ld: 3032530

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Renal Denervation (RDN) Therapy was estimated to be worth US$ 937.5 million in 2023 and is forecast to a readjusted size of US$ 8023.6 million by 2030 with a CAGR of 36.4% during the forecast period 2024-2030
North American market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Renal Denervation (RDN) Therapy Market Size(US$)

M= millions and B=billions

QYRLogo
Asia-Pacific market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Renal Denervation (RDN) Therapy include Medtronic (Covidien), ReCor, Johnson & Johnson, Boston Scientific, Shanghai Golden Leaf Med Tec Co., Ltd, Bio-Heart, SyMap Medical, Venus Medtech and Shanghai Microport Ep Medtech Co.,Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Renal Denervation (RDN) Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Renal Denervation (RDN) Therapy by region & country, by Type, and by Application.

The Renal Denervation (RDN) Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Denervation (RDN) Therapy.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Renal Denervation (RDN) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Forecasted Market Size in 2030

  • US$ 8023.6 million

  • CAGR(2024-2030)

  • 36.4%

  • Market Size Available for Years

  • 2024-2030

  • Global Renal Denervation (RDN) Therapy Companies Covered

  • Medtronic (Covidien)

    ReCor

    Johnson & Johnson

    Boston Scientific

    Shanghai Golden Leaf Med Tec Co., Ltd

    Bio-Heart

    SyMap Medical

    Venus Medtech

    Shanghai Microport Ep Medtech Co.,Ltd.

    Cryofocus Medtech

  • Global Renal Denervation (RDN) Therapy Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Renal Denervation (RDN) Therapy Market, Segment by Type

  • Radio Frequency

    Ultrasonic

  • Global Renal Denervation (RDN) Therapy Market, Segment by Application

  • Hospital

    Clinic

    Other

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Renal Denervation (RDN) Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Renal Denervation (RDN) Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Renal Denervation (RDN) Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Renal Denervation (RDN) Therapy Product Introduction
    1.2 Global Renal Denervation (RDN) Therapy Market Size Forecast
    1.3 Renal Denervation (RDN) Therapy Market Trends & Drivers
        1.3.1 Renal Denervation (RDN) Therapy Industry Trends
        1.3.2 Renal Denervation (RDN) Therapy Market Drivers & Opportunity
        1.3.3 Renal Denervation (RDN) Therapy Market Challenges
        1.3.4 Renal Denervation (RDN) Therapy Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Renal Denervation (RDN) Therapy Players Revenue Ranking (2023)
    2.2 Global Renal Denervation (RDN) Therapy Revenue by Company (2019-2024)
    2.3 Key Companies Renal Denervation (RDN) Therapy Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Renal Denervation (RDN) Therapy Product Offered
    2.5 Key Companies Time to Begin Mass Production of Renal Denervation (RDN) Therapy
    2.6 Renal Denervation (RDN) Therapy Market Competitive Analysis
        2.6.1 Renal Denervation (RDN) Therapy Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Renal Denervation (RDN) Therapy Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation (RDN) Therapy as of 2023)
    2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Radio Frequency
        3.1.2 Ultrasonic
    3.2 Global Renal Denervation (RDN) Therapy Sales Value by Type
        3.2.1 Global Renal Denervation (RDN) Therapy Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Renal Denervation (RDN) Therapy Sales Value, by Type (2019-2030)
        3.2.3 Global Renal Denervation (RDN) Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Other
    4.2 Global Renal Denervation (RDN) Therapy Sales Value by Application
        4.2.1 Global Renal Denervation (RDN) Therapy Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Renal Denervation (RDN) Therapy Sales Value, by Application (2019-2030)
        4.2.3 Global Renal Denervation (RDN) Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
    5.1 Global Renal Denervation (RDN) Therapy Sales Value by Region
        5.1.1 Global Renal Denervation (RDN) Therapy Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Renal Denervation (RDN) Therapy Sales Value by Region (2019-2024)
        5.1.3 Global Renal Denervation (RDN) Therapy Sales Value by Region (2025-2030)
        5.1.4 Global Renal Denervation (RDN) Therapy Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        5.2.2 North America Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        5.3.2 Europe Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        5.4.2 Asia Pacific Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        5.5.2 South America Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        5.6.2 Middle East & Africa Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value
    6.3 United States
        6.3.1 United States Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.3.2 United States Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.4.2 Europe Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.5.2 China Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.6.2 Japan Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.7.2 South Korea Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.8.2 Southeast Asia Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Renal Denervation (RDN) Therapy Sales Value, 2019-2030
        6.9.2 India Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Renal Denervation (RDN) Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
    7.1 Medtronic (Covidien)
        7.1.1 Medtronic (Covidien) Profile
        7.1.2 Medtronic (Covidien) Main Business
        7.1.3 Medtronic (Covidien) Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.1.4 Medtronic (Covidien) Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.1.5 Medtronic (Covidien) Recent Developments
    7.2 ReCor
        7.2.1 ReCor Profile
        7.2.2 ReCor Main Business
        7.2.3 ReCor Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.2.4 ReCor Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.2.5 ReCor Recent Developments
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Profile
        7.3.2 Johnson & Johnson Main Business
        7.3.3 Johnson & Johnson Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.3.4 Johnson & Johnson Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.3.5 Boston Scientific Recent Developments
    7.4 Boston Scientific
        7.4.1 Boston Scientific Profile
        7.4.2 Boston Scientific Main Business
        7.4.3 Boston Scientific Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.4.4 Boston Scientific Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.4.5 Boston Scientific Recent Developments
    7.5 Shanghai Golden Leaf Med Tec Co., Ltd
        7.5.1 Shanghai Golden Leaf Med Tec Co., Ltd Profile
        7.5.2 Shanghai Golden Leaf Med Tec Co., Ltd Main Business
        7.5.3 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.5.4 Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.5.5 Shanghai Golden Leaf Med Tec Co., Ltd Recent Developments
    7.6 Bio-Heart
        7.6.1 Bio-Heart Profile
        7.6.2 Bio-Heart Main Business
        7.6.3 Bio-Heart Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.6.4 Bio-Heart Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.6.5 Bio-Heart Recent Developments
    7.7 SyMap Medical
        7.7.1 SyMap Medical Profile
        7.7.2 SyMap Medical Main Business
        7.7.3 SyMap Medical Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.7.4 SyMap Medical Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.7.5 SyMap Medical Recent Developments
    7.8 Venus Medtech
        7.8.1 Venus Medtech Profile
        7.8.2 Venus Medtech Main Business
        7.8.3 Venus Medtech Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.8.4 Venus Medtech Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.8.5 Venus Medtech Recent Developments
    7.9 Shanghai Microport Ep Medtech Co.,Ltd.
        7.9.1 Shanghai Microport Ep Medtech Co.,Ltd. Profile
        7.9.2 Shanghai Microport Ep Medtech Co.,Ltd. Main Business
        7.9.3 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.9.4 Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.9.5 Shanghai Microport Ep Medtech Co.,Ltd. Recent Developments
    7.10 Cryofocus Medtech
        7.10.1 Cryofocus Medtech Profile
        7.10.2 Cryofocus Medtech Main Business
        7.10.3 Cryofocus Medtech Renal Denervation (RDN) Therapy Products, Services and Solutions
        7.10.4 Cryofocus Medtech Renal Denervation (RDN) Therapy Revenue (US$ Million) & (2019-2024)
        7.10.5 Cryofocus Medtech Recent Developments
8 Industry Chain Analysis
    8.1 Renal Denervation (RDN) Therapy Industrial Chain
    8.2 Renal Denervation (RDN) Therapy Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Renal Denervation (RDN) Therapy Sales Model
        8.5.2 Sales Channel
        8.5.3 Renal Denervation (RDN) Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Renal Denervation (RDN) Therapy Market Trends
    Table 2. Renal Denervation (RDN) Therapy Market Drivers & Opportunity
    Table 3. Renal Denervation (RDN) Therapy Market Challenges
    Table 4. Renal Denervation (RDN) Therapy Market Restraints
    Table 5. Global Renal Denervation (RDN) Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Renal Denervation (RDN) Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Renal Denervation (RDN) Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Renal Denervation (RDN) Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Renal Denervation (RDN) Therapy
    Table 10. Global Renal Denervation (RDN) Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation (RDN) Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Renal Denervation (RDN) Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Renal Denervation (RDN) Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Renal Denervation (RDN) Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Renal Denervation (RDN) Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Renal Denervation (RDN) Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Renal Denervation (RDN) Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Renal Denervation (RDN) Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Renal Denervation (RDN) Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Renal Denervation (RDN) Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Renal Denervation (RDN) Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Renal Denervation (RDN) Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Renal Denervation (RDN) Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Renal Denervation (RDN) Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Renal Denervation (RDN) Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Renal Denervation (RDN) Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Medtronic (Covidien) Basic Information List
    Table 32. Medtronic (Covidien) Description and Business Overview
    Table 33. Medtronic (Covidien) Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Medtronic (Covidien) (2019-2024)
    Table 35. Medtronic (Covidien) Recent Developments
    Table 36. ReCor Basic Information List
    Table 37. ReCor Description and Business Overview
    Table 38. ReCor Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of ReCor (2019-2024)
    Table 40. ReCor Recent Developments
    Table 41. Johnson & Johnson Basic Information List
    Table 42. Johnson & Johnson Description and Business Overview
    Table 43. Johnson & Johnson Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Johnson & Johnson (2019-2024)
    Table 45. Johnson & Johnson Recent Developments
    Table 46. Boston Scientific Basic Information List
    Table 47. Boston Scientific Description and Business Overview
    Table 48. Boston Scientific Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Boston Scientific (2019-2024)
    Table 50. Boston Scientific Recent Developments
    Table 51. Shanghai Golden Leaf Med Tec Co., Ltd Basic Information List
    Table 52. Shanghai Golden Leaf Med Tec Co., Ltd Description and Business Overview
    Table 53. Shanghai Golden Leaf Med Tec Co., Ltd Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Shanghai Golden Leaf Med Tec Co., Ltd (2019-2024)
    Table 55. Shanghai Golden Leaf Med Tec Co., Ltd Recent Developments
    Table 56. Bio-Heart Basic Information List
    Table 57. Bio-Heart Description and Business Overview
    Table 58. Bio-Heart Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Bio-Heart (2019-2024)
    Table 60. Bio-Heart Recent Developments
    Table 61. SyMap Medical Basic Information List
    Table 62. SyMap Medical Description and Business Overview
    Table 63. SyMap Medical Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of SyMap Medical (2019-2024)
    Table 65. SyMap Medical Recent Developments
    Table 66. Venus Medtech Basic Information List
    Table 67. Venus Medtech Description and Business Overview
    Table 68. Venus Medtech Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Venus Medtech (2019-2024)
    Table 70. Venus Medtech Recent Developments
    Table 71. Shanghai Microport Ep Medtech Co.,Ltd. Basic Information List
    Table 72. Shanghai Microport Ep Medtech Co.,Ltd. Description and Business Overview
    Table 73. Shanghai Microport Ep Medtech Co.,Ltd. Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Shanghai Microport Ep Medtech Co.,Ltd. (2019-2024)
    Table 75. Shanghai Microport Ep Medtech Co.,Ltd. Recent Developments
    Table 76. Cryofocus Medtech Basic Information List
    Table 77. Cryofocus Medtech Description and Business Overview
    Table 78. Cryofocus Medtech Renal Denervation (RDN) Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Renal Denervation (RDN) Therapy Business of Cryofocus Medtech (2019-2024)
    Table 80. Cryofocus Medtech Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Renal Denervation (RDN) Therapy Downstream Customers
    Table 84. Renal Denervation (RDN) Therapy Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Renal Denervation (RDN) Therapy Product Picture
    Figure 2. Global Renal Denervation (RDN) Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Renal Denervation (RDN) Therapy Report Years Considered
    Figure 5. Global Renal Denervation (RDN) Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Renal Denervation (RDN) Therapy Revenue in 2023
    Figure 7. Renal Denervation (RDN) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Radio Frequency Picture
    Figure 9. Ultrasonic Picture
    Figure 10. Global Renal Denervation (RDN) Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Renal Denervation (RDN) Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Other
    Figure 15. Global Renal Denervation (RDN) Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Renal Denervation (RDN) Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Renal Denervation (RDN) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Renal Denervation (RDN) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Renal Denervation (RDN) Therapy Sales Value (%), (2019-2030)
    Figure 28. United States Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Renal Denervation (RDN) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Renal Denervation (RDN) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Renal Denervation (RDN) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. Renal Denervation (RDN) Therapy Industrial Chain
    Figure 50. Renal Denervation (RDN) Therapy Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

The global market for Renal Denervation (RDN) Therapy was estimated to be worth US$ 937.5 million in 2023 and is forecast to a readjusted size of US$ 8023.6 million by 2030 with a CAGR of 36.4% during the forecast period 2024-2030
North American market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Renal Denervation (RDN) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Renal Denervation (RDN) Therapy include Medtronic (Covidien), ReCor, Johnson & Johnson, Boston Scientific, Shanghai Golden Leaf Med Tec Co., Ltd, Bio-Heart, SyMap Medical, Venus Medtech and Shanghai Microport Ep Medtech Co.,Ltd., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Renal Denervation (RDN) Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Renal Denervation (RDN) Therapy by region & country, by Type, and by Application.

The Renal Denervation (RDN) Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Denervation (RDN) Therapy.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Renal Denervation (RDN) Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Renal Denervation (RDN) Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Renal Denervation (RDN) Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Renal Denervation (RDN) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-01-02

Pages: 104 Pages

Report ld: 3032530

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Online

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Online

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now